Daniel L. Alkon, Chief Scientific Officer at Synaptogenix, Inc. (SNPX), bought 10,000 shares at $8.26 ($83K) on 2021-06-14, disclosed to the SEC on 2021-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.